Quidel MicroVue Intact PTH EIA, Model 8044. An enzyme immunoassay for the quantification of Inta...

FDA Device Recall #Z-1520-2018 — Class III — October 26, 2016

Recall Summary

Recall Number Z-1520-2018
Classification Class III — Low risk
Date Initiated October 26, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Diagnostic Hybrids, Inc.
Location Athens, OH
Product Type Devices
Quantity 26

Product Description

Quidel MicroVue Intact PTH EIA, Model 8044. An enzyme immunoassay for the quantification of Intact Parathyroid Hormone (PTH) in serum.

Reason for Recall

There may be a loss of separation between Calibrators A and B which may impact the assay calibration at the lower end of the assay.

Distribution Pattern

The product was distributed to the following countries: Singapore, Switzerland

Lot / Code Information

Lot 068259

Other Recalls from Diagnostic Hybrids, Inc.

Recall # Classification Product Date
Z-1496-2018 Class II MicroVue CIC-C1q EIA, Model A001. An enzyme im... Apr 4, 2017
Z-1797-2018 Class II MicroVue BAP EIA, Model 8012, provides a quanti... Jul 14, 2016
Z-1499-2018 Class III MicroVue SC5b-9 Plus EIA (CE-IVD), Model A029. ... Nov 3, 2015
Z-1498-2018 Class III MicroVue SC5b-9 Plus EIA (RUO), Model A020. Res... Nov 3, 2015
Z-1497-2018 Class III MicroVue CIC-C1q EIA, Model A001. The MicroVue ... Nov 3, 2015

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.